Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways

BACKGROUND: In high-grade serous ovarian cancer (HGSOC), intrinsic and/or acquired resistance against platinum-containing chemotherapy is a major obstacle for successful treatment. A low frequency of somatic mutations but frequent epigenetic alterations, including DNA methylation in HGSOC tumors, pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomar, Tushar, de Jong, Steven, Alkema, Nicolette G., Hoekman, Rieks L., Meersma, Gert Jan, Klip, Harry G., van der Zee, Ate GJ, Wisman, G. Bea A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072346/
https://www.ncbi.nlm.nih.gov/pubmed/27765068
http://dx.doi.org/10.1186/s13073-016-0361-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072346/
https://www.ncbi.nlm.nih.gov/pubmed/27765068
http://dx.doi.org/10.1186/s13073-016-0361-5

Ejemplares similares